申请人:Marcin Lawrence R.
公开号:US20110015175A1
公开(公告)日:2011-01-20
The present disclosure provides a series of compounds of the formula (I)
which reduce β-amyloid peptide (β-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions affected by β-amyloid peptide (β-AP) production.
本公开提供了一系列化合物的公式(I),它们能够减少β-淀粉样肽(β-AP)的产生,并且在治疗阿尔茨海默病和其他受β-淀粉样肽(β-AP)产生影响的疾病方面非常有用。